These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31692974)

  • 1. Kallikrein 6 protease advances colon tumorigenesis
    Chen H; Sells E; Pandey R; Abril ER; Hsu CH; Krouse RS; Nagle RB; Pampalakis G; Sotiropoulou G; Ignatenko NA
    Oncotarget; 2019 Oct; 10(58):6062-6078. PubMed ID: 31692974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific microRNA-mRNA Regulatory Network of Colon Cancer Invasion Mediated by Tissue Kallikrein-Related Peptidase 6.
    Sells E; Pandey R; Chen H; Skovan BA; Cui H; Ignatenko NA
    Neoplasia; 2017 May; 19(5):396-411. PubMed ID: 28431272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kallikrein-Related Peptidase 6 (KLK6) as a Contributor toward an Aggressive Cancer Cell Phenotype: A Potential Role in Colon Cancer Peritoneal Metastasis.
    Bouzid H; Soualmia F; Oikonomopoulou K; Soosaipillai A; Walker F; Louati K; Lo Dico R; Pocard M; El Amri C; Ignatenko NA; Darmoul D
    Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Pathways Associated with Kallikrein 6 Overexpression in Colorectal Cancer.
    Pandey R; Zhou M; Chen Y; Darmoul D; Kisiel CC; Nfonsam VN; Ignatenko NA
    Genes (Basel); 2021 May; 12(5):. PubMed ID: 34065672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential roles of kallikrein-related peptidase 6 in malignant transformation and ΔNp63β-mediated epithelial-mesenchymal transition of oral squamous cell carcinoma.
    Kaneko N; Kawano S; Yasuda K; Hashiguchi Y; Sakamoto T; Matsubara R; Goto Y; Jinno T; Maruse Y; Morioka M; Hattori T; Tanaka S; Tanaka H; Kiyoshima T; Nakamura S
    Oral Oncol; 2017 Dec; 75():148-157. PubMed ID: 29224812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer.
    Ogawa K; Utsunomiya T; Mimori K; Tanaka F; Inoue H; Nagahara H; Murayama S; Mori M
    Clin Cancer Res; 2005 Apr; 11(8):2889-93. PubMed ID: 15837738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing of kallikrein-related peptidase 6 attenuates the proliferation, migration, and invasion of gastric cancer cells through inhibition of epithelial-mesenchymal transition.
    Zhou D; He Y; Li H; Huang W
    Exp Ther Med; 2021 Jul; 22(1):770. PubMed ID: 34055069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kallikrein-related peptidase-6 (KLK6) mRNA expression is an independent prognostic tissue biomarker of poor disease-free and overall survival in colorectal adenocarcinoma.
    Christodoulou S; Alexopoulou DK; Kontos CK; Scorilas A; Papadopoulos IN
    Tumour Biol; 2014 May; 35(5):4673-85. PubMed ID: 24430362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients.
    Schrader CH; Kolb M; Zaoui K; Flechtenmacher C; Grabe N; Weber KJ; Hielscher T; Plinkert PK; Hess J
    Mol Cancer; 2015 May; 14():107. PubMed ID: 25990935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kallikrein 6 is a mediator of K-RAS-dependent migration of colon carcinoma cells.
    Henkhaus RS; Gerner EW; Ignatenko NA
    Biol Chem; 2008 Jun; 389(6):757-64. PubMed ID: 18627290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kallikrein-related peptidase 6 (KLK6) expression in the progression of colon adenoma to carcinoma.
    Vakrakou A; Devetzi M; Papachristopoulou G; Malachias A; Scorilas A; Xynopoulos D; Talieri M
    Biol Chem; 2014 Sep; 395(9):1105-17. PubMed ID: 25153391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-silico analysis of kallikrein gene expression in pancreatic and colon cancers.
    Yousef GM; Borgoño CA; Popalis C; Yacoub GM; Polymeris ME; Soosaipillai A; Diamandis EP
    Anticancer Res; 2004; 24(1):43-51. PubMed ID: 15015574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation and prognostic significance of human tissue kallikrein-related peptidase 6 (KLK6) in colorectal cancer.
    Petraki C; Dubinski W; Scorilas A; Saleh C; Pasic MD; Komborozos V; Khalil B; Gabril MY; Streutker C; Diamandis EP; Yousef GM
    Pathol Res Pract; 2012 Feb; 208(2):104-8. PubMed ID: 22285222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma.
    White NM; Mathews M; Yousef GM; Prizada A; Popadiuk C; Doré JJ
    Br J Cancer; 2009 Oct; 101(7):1107-13. PubMed ID: 19707197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic and biological significance of kallikrein 6 overexpression in human gastric cancer.
    Nagahara H; Mimori K; Utsunomiya T; Barnard GF; Ohira M; Hirakawa K; Mori M
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6800-6. PubMed ID: 16203767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A tumor-protective role for human kallikrein-related peptidase 6 in breast cancer mediated by inhibition of epithelial-to-mesenchymal transition.
    Pampalakis G; Prosnikli E; Agalioti T; Vlahou A; Zoumpourlis V; Sotiropoulou G
    Cancer Res; 2009 May; 69(9):3779-87. PubMed ID: 19383923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of human tissue kallikrein-related peptidases 6 and 10 expression in early gastroesophageal adenocarcinoma.
    Grin A; Samaan S; Tripathi M; Rotondo F; Kovacs K; Bassily MN; Yousef GM
    Hum Pathol; 2015 Apr; 46(4):541-8. PubMed ID: 25649006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stromal cell-associated expression of kallikrein-related peptidase 6 (KLK6) indicates poor prognosis of ovarian cancer patients.
    Seiz L; Dorn J; Kotzsch M; Walch A; Grebenchtchikov NI; Gkazepis A; Schmalfeldt B; Kiechle M; Bayani J; Diamandis EP; Langer R; Sweep FC; Schmitt M; Magdolen V
    Biol Chem; 2012 Apr; 393(5):391-401. PubMed ID: 22505521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Let‑7i‑5p inhibits the proliferation and metastasis of colon cancer cells by targeting kallikrein‑related peptidase 6.
    Song J; Wang L; Ma Q; Yang Y; Yang Z; Wang B; He N
    Oncol Rep; 2018 Sep; 40(3):1459-1466. PubMed ID: 30015976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kallikrein-related peptidase 6 induces chemotherapeutic resistance by attenuating auranofin-induced cell death through activation of autophagy in gastric cancer.
    Kim TW; Lee SJ; Kim JT; Kim SJ; Min JK; Bae KH; Jung H; Kim BY; Lim JS; Yang Y; Yoon DY; Choe YK; Lee HG
    Oncotarget; 2016 Dec; 7(51):85332-85348. PubMed ID: 27863404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.